Correlation Between Sartorius Stedim and Sogeclair

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Sogeclair at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Sogeclair into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Sogeclair SA, you can compare the effects of market volatilities on Sartorius Stedim and Sogeclair and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Sogeclair. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Sogeclair.

Diversification Opportunities for Sartorius Stedim and Sogeclair

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sartorius and Sogeclair is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Sogeclair SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sogeclair SA and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Sogeclair. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sogeclair SA has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Sogeclair go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Sogeclair

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.76 times more return on investment than Sogeclair. However, Sartorius Stedim Biotech is 1.32 times less risky than Sogeclair. It trades about 0.27 of its potential returns per unit of risk. Sogeclair SA is currently generating about 0.11 per unit of risk. If you would invest  18,730  in Sartorius Stedim Biotech on October 26, 2024 and sell it today you would earn a total of  1,950  from holding Sartorius Stedim Biotech or generate 10.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Sogeclair SA

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Sogeclair SA 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sogeclair SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Sogeclair may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Sartorius Stedim and Sogeclair Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Sogeclair

The main advantage of trading using opposite Sartorius Stedim and Sogeclair positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Sogeclair can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sogeclair will offset losses from the drop in Sogeclair's long position.
The idea behind Sartorius Stedim Biotech and Sogeclair SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.